Overview
This joint resolution exercises Congress's authority under the Congressional Review Act to formally disapprove a rule issued by the Centers for Medicare & Medicaid Services implementing prior authorization requirements for select Medicare services under the Wasteful and Inappropriate Services Reduction (WISeR) Model. The resolution's singular objective is to nullify the CMS rule published on July 1, 2025, preventing it from taking effect and stripping it of any legal force. The resolution reflects congressional opposition to the mandatory prior authorization framework CMS sought to impose on Medicare providers and beneficiaries, with broad Democratic Senate support driving the disapproval effort. By invoking the CRA mechanism, Congress asserts its oversight role over executive agency rulemaking in the Medicare program.
Key Points
- Nullifies the CMS WISeR Model prior authorization rule published July 1, 2025
- Invokes Congressional Review Act disapproval authority
- Prevents implementation of mandatory prior authorization for select Medicare services
- Reflects broad bipartisan Senate opposition to the CMS rulemaking
Legal References
- Congressional Review Act, 5 U.S.C. Chapter 8
- 5 U.S.C. § 802(c)
Core Provisions
The resolution contains a single operative provision: Congress disapproves the rule submitted by CMS relating to the Medicare Program's implementation of prior authorization for select services under the WISeR Model, and that rule shall have no force or effect [§1]. The rule in question was published on July 1, 2025, and would have established a prior authorization framework requiring Medicare providers to obtain advance approval before delivering certain designated services deemed potentially wasteful or inappropriate by CMS. The disapproval is categorical and immediate — no partial implementation, phase-out period, or savings clause preserves any portion of the rule. The resolution does not amend existing Medicare statutes, create new programs, or authorize funding; it operates exclusively as a veto of the agency's regulatory action.
Legal References
- 5 U.S.C. § 801 et seq. (Congressional Review Act)
- Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model, 90 Fed. Reg. (July 1, 2025)
Implementation
Implementation of this resolution is self-executing upon enactment. No agency action, rulemaking, or regulatory guidance is required to give effect to the disapproval — the CMS WISeR Model prior authorization rule is rendered void by operation of law. CMS and the Department of Health and Human Services bear the administrative responsibility of unwinding any preparatory steps taken toward implementing the now-nullified rule, including halting any prior authorization review processes, provider notification systems, or compliance infrastructure that may have been established in anticipation of the rule's effective date. The Congressional Review Act further prohibits CMS from issuing a substantially similar rule without new congressional authorization, creating a lasting regulatory constraint on the agency's ability to reimpose comparable prior authorization requirements under the WISeR framework. The resolution reached the Senate floor through a committee discharge petition under 5 U.S.C. § 802(c), bypassing the standard committee markup process after being referred to the Senate Finance Committee on June 24, 2026.
Legal References
- 5 U.S.C. § 801(b)(2) (prohibition on substantially similar rules)
- 5 U.S.C. § 802(c) (committee discharge procedure)
Impact
The primary beneficiaries of this disapproval are Medicare beneficiaries and healthcare providers who would have been subject to the prior authorization requirements under the WISeR Model. Beneficiaries gain continued access to select Medicare services without the delays and administrative burdens associated with prior authorization review processes. Providers — including hospitals, physicians, and other Medicare-participating entities — are relieved of the compliance costs, documentation requirements, and potential claim denials that the WISeR Model would have imposed. From a fiscal perspective, the disapproval eliminates the projected cost savings CMS anticipated from reducing wasteful and inappropriate service utilization, meaning Medicare expenditures will remain higher than they would have been under the rule. The administrative burden on CMS is also affected, as the agency must redirect resources away from WISeR implementation. The disapproval has no sunset provision and operates as a permanent nullification of the specific rule, though it does not foreclose future legislative or regulatory efforts to address Medicare service utilization through alternative mechanisms.
Legal References
- 5 U.S.C. § 801(f) (effect of disapproval on rule)
Legal Framework
The constitutional basis for this joint resolution rests on Congress's Article I authority over federal spending programs, including Medicare, and its plenary power to define the scope of executive agency authority. The operative legal mechanism is the Congressional Review Act, codified at Chapter 8 of Title 5 of the United States Code, which grants Congress the authority to disapprove any rule submitted by a federal agency through a joint resolution passed by both chambers and presented to the President. Upon enactment, the disapproved rule has no force or effect as a matter of statutory law. The CRA's anti-recurrence provision at 5 U.S.C. § 801(b)(2) prohibits CMS from promulgating a new rule that is substantially the same as the disapproved rule unless Congress subsequently enacts authorizing legislation. The resolution does not preempt state law, as it operates exclusively within the federal Medicare regulatory framework. Judicial review of CRA disapprovals is substantially limited — courts have generally held that the political question doctrine and the CRA's own structure preclude judicial second-guessing of congressional disapproval actions, though the scope of the anti-recurrence prohibition may be subject to litigation if CMS attempts to issue a successor rule.
Legal References
- U.S. Const. Art. I, § 8 (congressional spending power)
- 5 U.S.C. §§ 801-808 (Congressional Review Act)
- 5 U.S.C. § 801(b)(2) (substantially similar rule prohibition)
- 5 U.S.C. § 802 (joint resolution of disapproval procedures)
- 5 U.S.C. § 802(c) (discharge from committee)
Critical Issues
The most significant policy concern raised by this disapproval is the fiscal impact on Medicare solvency. The WISeR Model was designed to reduce wasteful and inappropriate service utilization, and its nullification removes a cost-containment mechanism from the Medicare program at a time of ongoing fiscal pressure. Opponents of the disapproval argue that prior authorization, when properly implemented, is an effective tool for reducing unnecessary procedures and protecting beneficiaries from low-value care. The disapproval also raises implementation challenges for CMS, which must now determine how to address the underlying policy concerns that motivated the WISeR rulemaking without running afoul of the CRA's anti-recurrence prohibition. The breadth of that prohibition — specifically, what constitutes a 'substantially similar' rule — is legally unsettled and could generate litigation if CMS pursues alternative prior authorization frameworks. From a political standpoint, the resolution's advancement via committee discharge petition rather than regular order signals significant Senate opposition to the rule but also highlights the procedural tensions inherent in CRA disapprovals. Finally, the disapproval does not address the underlying statutory authority CMS relied upon to promulgate the WISeR rule, leaving open the question of whether Congress intends to legislatively constrain or redirect CMS's prior authorization authority in Medicare more broadly.
Legal References
- 5 U.S.C. § 801(b)(2) (substantially similar rule prohibition — scope uncertain)
- Medicare Act, 42 U.S.C. § 1395 et seq. (underlying CMS statutory authority)